Wall Street analysts have issued a series of influential calls affecting major stocks, including Nvidia, Apple, and Tesla. Firms like JPMorgan and Goldman Sachs provided new ratings and price targets, highlighting strategic opportunities and potential headwinds for various companies. Notably, analyst sentiment remains largely positive for key technology and consumer discretionary stocks despite varying market conditions.
Key upgrades included Tesla and Chipotle by JPMorgan, while companies like Lululemon and CrowdStrike saw downgrades. Analysts are closely watching upcoming events, such as Qualcomm’s investor day and Apple’s WWDC, for further insights into company strategies and future growth prospects.
Friday's market action was shaped by a flurry of analyst calls, with significant attention focused on tech giants like Nvidia and Apple, alongside consumer-focused companies such as Tesla and Chipotle. Analysts at major firms including JPMorgan, Bank of America, UBS, and Goldman Sachs issued new ratings and price targets, offering insights into their outlook for these prominent stocks.
JPMorgan Adds Positive Catalyst Watch to Qualcomm: Ahead of Qualcomm's investor day on June 24th, JPMorgan reiterated its neutral rating but added a positive catalyst watch. The firm anticipates the event will highlight the company's strategy for growth and diversification in the evolving AI landscape.
Bank of America Remains Bullish on Nvidia: Following a meeting with management, Bank of America reiterated its 'Buy' rating on Nvidia, stating the stock is performing exceptionally well. Recent engagements, including a GTC Taipei keynote and meetings with the CFO and IR Director, have reinforced the firm's positive stance.
UBS Initiates Coverage on Homebuilders: UBS started coverage on Champion Homes (SKY) and Cavco (CVCO) with 'Buy' ratings. The firm believes these companies are well-positioned to benefit from a housing market that is addressing affordability challenges and appears to be bottoming.
Goldman Sachs's New Picks: Goldman Sachs initiated coverage on Concentra (CON) with a 'Buy' rating and a $30 price target, citing durable growth drivers. The firm also initiated coverage on Sotera Health (SHC) with a 'Buy' rating and a $20 price target, highlighting its durable business model.
BTIG Downgrades Lululemon: BTIG downgraded Lululemon to 'Hold' from 'Buy,' citing reduced visibility. While the first quarter was largely in line, a deceleration towards the end of the quarter suggests ongoing challenges, with second-quarter sales expected to decline for the first time post-COVID.
Roth Capital Initiates Coya Therapeutics: Roth Capital initiated coverage on Coya Therapeutics (COYA) with a 'Buy' rating and a $12 price target, expressing a bullish outlook on the biotech company.
Evercore ISI Upgrades FormFactor: Evercore ISI upgraded FormFactor to 'Outperform' from 'In Line' with a $155 price target. The firm sees a compelling risk/reward profile driven by AI tailwinds and expects significant EPS growth, justifying a higher valuation multiple.
Deutsche Bank Bullish on Robinhood and Onto Innovation: Deutsche Bank reiterated its 'Buy' rating on Robinhood, raising its price target to $98 from $88, citing increased prediction market volumes following the launch of Rothera. The firm also initiated coverage on Onto Innovation (ONTO) with a 'Buy' rating and a $350 price target, viewing it as a strong player in the semiconductor equipment market.
Berenberg Downgrades CrowdStrike: Berenberg downgraded CrowdStrike to 'Hold' from 'Buy,' suggesting the stock is priced to perfection following strong first-quarter results. The firm noted that while the platform is high-quality, current expectations may be fully reflected in the stock price.
Goldman Sachs on Guardant Health: Goldman Sachs initiated coverage on Guardant Health (GH) with a 'Buy' rating, recognizing it as a market leader in therapy selection with upcoming catalysts and a clear path to profitability.
Rosenblatt Raises Disney Price Target: Rosenblatt reiterated its 'Buy' rating on Disney, increasing its price target to $126 from $121. The firm's updated estimates reflect a more profitable movie slate for fiscal year 2026 and positive indicators for the company's Parks division.
Baird's Bearish Call on Coinbase: Baird designated Coinbase (COIN) as a 'Bearish Fresh Pick.' The firm expects second-quarter revenue to miss estimates due to weaker trading volumes and believes the CLARITY Act may not pass until after the mid-term elections.
Citi Upgrades Shattuck Labs: Citi upgraded Shattuck Labs to 'Buy' from 'Neutral' and initiated a positive catalyst watch ahead of initial Phase 1 data for its antibody drug, SL-325, expected in the second quarter of 2026.
JPMorgan Upgrades Tesla and Chipotle: JPMorgan upgraded Tesla to 'Neutral' from 'Underperform,' citing its unique vertical integration and rapid technology development. The firm also upgraded Chipotle to 'Overweight' from 'Neutral,' identifying a rare valuation opportunity after meeting with management.
Wedbush Bullish on Apple Ahead of WWDC: Wedbush reiterated its 'Outperform' rating on Apple, expressing optimism heading into the Worldwide Developers Conference (WWDC). The firm anticipates Apple will unveil its AI strategy, which is expected to further energize the developer ecosystem.
Bernstein Upgrades Kanzhun: Bernstein upgraded Kanzhun (Boss Zhipin) to 'Outperform' from 'Market Perform' with an $18 price target. The firm believes investors should buy the dip, citing the company's strong execution in a niche market and a revenue stream increasingly diversified beyond traditional white-collar jobs.
